Cosmos Health Inc.
COSM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.01 | -0.02 | 0.00 |
| FCF Yield | -63.51% | -146.98% | -173.49% | -360.80% |
| EV / EBITDA | -1.75 | -1.49 | -0.01 | -7.61 |
| Quality | ||||
| ROIC | -40.57% | -43.46% | -14.50% | -13.49% |
| Gross Margin | 7.92% | 8.15% | 11.83% | 14.81% |
| Cash Conversion Ratio | 0.48 | 0.84 | 1.08 | 0.89 |
| Growth | ||||
| Revenue 3-Year CAGR | 2.63% | -1.73% | -3.14% | 12.33% |
| Free Cash Flow Growth | 67.20% | -62.61% | -90.97% | 31.26% |
| Safety | ||||
| Net Debt / EBITDA | -0.83 | -0.50 | 0.98 | -7.03 |
| Interest Coverage | -15.36 | -25.20 | -1.88 | -1.27 |
| Efficiency | ||||
| Inventory Turnover | 11.51 | 10.24 | 12.86 | 15.22 |
| Cash Conversion Cycle | 56.96 | 95.45 | 109.03 | 125.67 |